In its final agreement to be purchased by publicly traded biopharmaceutical business Esperion Therapeutics, Inc., Corstasis Therapeutics Inc., a privately held commercial-stage biopharmaceutical company, received advice from Arnold & Porter.

Maynard Nexsen PC is happy to announce that Phillip D. Corley, Jr., a native of Birmingham, has joined the firm’s real estate practice.

For Grenke Italia’s benefit, Baker McKenzie helped the group of lending banks complete a financing deal.

LiquidStack, a world pioneer in liquid cooling technology for data centers with its headquarters located in Carrollton, Texas, has been acquired by Trane Technologies, a worldwide climate developer.

When Targa Resources Corp. offered $1.5 billion in senior notes, Gibson Dunn provided advice to the underwriters.

Immunic, Inc. received advice from Dentons about up to US$400 million in private placement financing, which included US$200 million in initial proceeds and the possibility of an additional US$200 million.

In order to help Andion CH4 (Andion) build a biomethane manufacturing facility from agricultural waste in Mirandola (Modena), Emilia-Romagna (Northen Italy), Norton Rose Fulbright has advised BNL BNP Paribas and Mediocredito Centrale on a €24 million project financing.

Gyre Therapeutics, Inc., a cutting-edge, commercial-stage biopharmaceutical business committed to developing fibrosis-first treatments across organ systems impacted by chronic illnesses, is receiving advice from Gibson Dunn on its purchase of Cullgen Inc.

In relation to GCM Grosvenor’s structured alternatives investment solution, Mayer Brown served as legal counsel, raising the total capital commitments to $625 million. GCM Grosvenor is a renowned global provider of alternative asset management solutions.

Jenifer Minsky has joined the Construction Law Practice of Smith, Gambrell & Russell, LLP (“SGR”) with great pleasure.